Universidad de Valladolid. Spain ; Inserm U. 188, Paris. Somatomedin and transferrin in celiac disease (CD).
Sulfation activity (Sm) and transferrin (Tf) were measured in 90 plasma samples from 39 children with CD classified 5 to 1 by intestinal biopsy performed at time of sampling : 10 before, 58 during gluten-free diet (GF), 22 after gluten reintroduction (GR). Sm was 0.32 ± 0.04 U/ml before GF, increased with GF from stages 5 to 1, to reach 1.23 ± 0.15, decreased at GR to 0.38 ± 0.06. Sm correlated to GF duration (r =0.781).
Correlation of Sm with growth velocity (V) was lacking at stages 5 to 2, and appeared at stage I (r = 0.778).
Tf decreased from a high value of 3.62 ± 0.15 gil at stage 5 to 2 .97 ± 0.14 after GF at stage I, rising to 3.35 ± 0.10 at GR. Tf correlated negatively with GF duration (r = -0.720) and positively to V on GF (r = 0.492) and GR (r = 0.601). Longitudinal studies from GF to GR and again GF confirmed the inverse trend of Sm and Tf variations. These data show that early catch-up growth in CD treated with GF does not relate to sulfation activity and may involve other factorll, such as Tf . Random plasma somatomedln-C levels were measured In 101 chIldren aged 7 months to 18 years wIth growth at or below the 5th percentile . 87 of 101 had short stature due to constitut ional delay or genetic predIsposItIon and 14 were growth hormone defIcIent. In the short nonnal group mean somatomedln-C levels were: 0-2 years: 0 .22i 0.02U/ml; 2-5 years: 0.28tO .06U/ml ; 5-12 years: 0.78tO.IU/ml; 12-18 years: 1.22tO.16U/ml; compared with 0.23tO.04U/ml In the growth hormone defIcIent chIldren. 55 of 101 had somatomedln-C levels of 0.5U/ml, and had one or more growth hormone stimulation tests. All 14 growth hormone defIcIent patIents fell Into thIs group (range: D.09-0.~7U/ml). The~I nonnal patlants In thIs group (growth horlIIOna 6ng/m1) were dlstlbuted alllOng the entire 87 nonnals as follows : 0-2 years : 10/10 ; 2-5 years: 19/23; 5-12 years : 11130; 12-18 years : 1/2~. There was consIderable overlap of values among growth hormone deficient and short normal children under 12 years of age. but a clear separation above 12 years . In 5 of 6 patients In whom 2 measurements were made, there were ..Jor differences In these levels . I) Random somatomedln-C levels lack specificIty In screenlpg for growth hormone deficiency under the age of 12 years. 2) The variation of levels In Individual patients necessitates further study to IdentIfy a possIble diurnal or pulsatIle secretory pattern. 3) A standardized tIme of sampling should be considered .
Depart.ents of Child Health and Medical Biochemistr,r, University of Manchester, England. The effecte of anti-leukaemic drugs on somatomedin production and cartilage responsiveness to somatomedin in vitro.
Drugs commonly used to treat children vith acute lymphoblastic leukaemia vere investigated i n vitro to determine cartilege responsiveness to 8Omatoaedin using the uptake of r.dioactive sulphate and th7midine by porcine cartilage .
Prednisolone and doxorubicin profoundly depress cartilage responsiveness .t doses vi thin therapeutic ranges and vincriatine and cytosine arabinoside produce lesser but significant inhibition.
Using rat liver per!Usionsit v.s possibl. to damonstrate that growth-hormone stimulated liver ;reduction of somatomedin activity is profoundly depressed by vinc stine and l):lNlrcaptopurin., is lovered by cyclophoaphamide and cytosine arabinoside but is unaffected by prednisol,ge and doxorubicin.
The poor growth of children vi th ALL during treatIlent 1187 be mediated by a drug-induced combination of diminished eomatomedin production and cartilage response to somatomedin. R. ROSENFELD.· S. KEMP. and R. HINTZ . Dept . of Pediatrics, Stanford University, St anford, California . Acute snd chronic somatomedin-C response to growth hormone: evaluation of correlation with age and growth rate .
The correlation between acute and chronic SM-C responses to hGH treatment of hypopituitary dwarfism, and t heir vslue in pr edi c ting growth rates were studied in 20 GH-defic1ent children. SM-C by RiA snd RRA was measured prior to hGH, 12 hours after 4 daily injections of hGH, 0 .1 U/kg , and after 6 months of hGH 0 .1 U/kg t .i. The correlation between SH-C by RRA and RIA was highly significant (r-0.92 on Day 1 and at 6 months, p < 0.001) . The acute SH-C response to hGH was predictive of chronic SH-C levels (Day 5 vs. 6 month SH-C. r-0.80. p <0 . 001) . However, individual SH-C responses were variable, with 7 children achieving SH-C levels >1 u/m! by Day 5, while 3 maintained levels < 0.10 u/m! . Although the annual growth rate increased from 3.6 + 0.1 to 6 .7 + 0.6 cmlyr, no correlation was observed between growth rate and baseline, acute or chronic SH-C levels. Children under 10 years of age had the smallest increment in SH-C, but the best growth rate. However, even when subdivided by age, no correlation was observed between 6 month SH-C and growth rates (r-O.lO, p >0.75 ). We conclude that (I) the acute SH-C response to hGH predicts chronic SH-C levels, (2) SH-C and growth response to hGH are age-dependent and (3 ) the level of SH-C elevation with hGH cannot predict growth response.
Effects of fast1nq and refeed1nq on qrawth hormone receptors 1nrat liver membranes .
The mechanism of the growth defect often associated with poor nutrition is not clear. We have studied the specific b1nd1nq of qrowth hormone (GIl) to liver membranes of 3 qroups of rats which were (F) fasted for 4 days, (R) refed for 3 days after fast1nq.!,"d (control s ) allowed free access to food. The spe cific bindinq of 125I-BGH (bovine GH) was low in microsomal membranes of (F) rats :
57 , that of controls. The number of somatotropic sites rather than the affinity of the bind1nq was affected. The lactoqenic sites as judqed on the bindinq of 125I-HGH (human GH) were notsiqnificantly reduced in membranes of (F) rats . The number of insulin receptors was elevated in microsomal membranes of (F) rats : 185 , that of controls ; this modification was associated with a decreased insu11nemia in (F) r a ts. But no c hange of the plasma GH was found in (F) and ( R) rats when compared t o controls; other factor(s) than the hormone level must regulate the somatotropic sites in this model . Refeedinq led to a cor r ec t i on of the bindinq of 125I-BGH and of 1 25I-Insulin to microsomal membranes. Decreased plasma somatomed!n bioactivity was -'lssociated with the low number of somatotropic receptors i n the l iver membranes of fasted rats ; it suggests a role of the GH liver receptors in the regulation of the plasma somatomedin actiV ity. A rsport(l) auggests that 8MB may inhibit prote..es with trypsin-like activity. Tbese protea.es could be concerned with the rel...e ot biolog1c.lly active growth tactors (IGP) trom their specitic carrier proteig. . The objectives ot this .tudy were to (a) es..ine it decrea.ed bigding ot 125 1 8MB occurs in serua tro. GBD chlldreg thus retlecting all bcrea.ed pool ot unbound 8MB . (b) To asplore the bind1gg characteri.tics ot 8MB. Puritied 8MB w.. labelled to a ..all specitic activity ot 209 vei/~g . Dilution curve. ot serua tro. GBD chlldreg (N = 15, 2 1/2 -~8Y) aIld ..e matched controls were .tud1ed. Atter 19cubatiog (4 C, 2h), tree trom bound label wa. separated with asaoniua SUlphate. The meall percentage ot label bound to diluted sera (12 .5 -50~1 in the ....y) trom GBD childr.n w.. lower thall tor control. (P <0.001 
